Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Zhonghua Yi Shi Za Zhi (Beijing, China : 1980)|May 17, 2002
[A brief history of adrenal gland surgery]Sixing Yang, Linglong WangExpert Opinion on Drug Delivery|August 12, 2009
Formulating protein therapeutics into particulate formsSixing Yang, Weien Yuan, Tuo JinCancer Biotherapy & Radiopharmaceuticals|June 20, 2018
Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5EYongbo Song, Chao Song, Sixing YangCurrent Pharmaceutical Biotechnology|December 29, 2011
Challenges and strategies in developing microneedle patches for transdermal delivery of protein and peptide therapeuticsFei Wu, Sixing Yang, Weien Yuan, et al.Cell Biochemistry and Biophysics|January 22, 2015
Modification of Antitumor Immunity and Tumor Microenvironment by Resveratrol in Mouse Renal Tumor ModelLiang Chen, Sixing Yang, Wenbiao Liao, et al.Urolithiasis|February 11, 2025
Advances in the mechanism of urinary proteins in calcium oxalate kidney stone formationMingcheng Shi, Xiaozhe Su, Heng Xiang, et al.Cellular Signalling|March 16, 2025
Protein succinylation mechanisms and potential targeted therapies in urinary diseaseYuanquan Lou, Caitao Dong, Qinhong Jiang, et al.Urolithiasis|March 3, 2025
Environmental determinants in the development of kidney stoneCaitao Dong, Yijun Yang, Bobo Cheng, et al.Journal of Cellular Physiology|December 12, 2018
Long noncoding RNA ATB participates in the development of renal cell carcinoma by downregulating p53 via binding to DNMT1Chao Song, Yunhe Xiong, Wenbiao Liao, et al.American Journal of Translational Research|September 10, 2019
MicroRNA-30a-3p functions as a tumor suppressor in renal cell carcinoma by targeting WNT2Lingqi Liu, Liang Chen, Tianpeng Wu, et al.Pageof 7